天津医药 ›› 2017, Vol. 45 ›› Issue (11): 1121-1123.doi: 10.11958/20170912

• 专题-心肌梗死 •    下一篇

急性心肌梗死的早期诊断和优化治疗

葛均波,戴宇翔
  

  1. 复旦大学附属中山医院心内科,上海市心血管病研究所
  • 收稿日期:2017-08-18 修回日期:2017-08-28 出版日期:2017-11-15 发布日期:2017-11-15
  • 通讯作者: 葛均波 E-mail:dai.yuxiang@hotmail.com
  • 基金资助:
    国家自然科学基金青年科学基金项目(81300095)

Early diagnosis and optimal treatment of acute myocardial infarction#br#

GE Jun-bo, DAI Yu-xiang #br# #br#   

  1. Department of Cardiology, the Affiliated Zhongshan Hospital of Fudan University, Institute of Cardiovascular Diseases in Shanghai
  • Received:2017-08-18 Revised:2017-08-28 Published:2017-11-15 Online:2017-11-15

摘要: 近年来,得益于急性心肌梗死(AMI)在早期诊断和早期再灌注治疗等方面的众多研究进展,欧洲和美国的指南及中国学界关于 AMI 的指南得到不断更新,指导着临床实践的不断进步。但我们需看到,AMI 仍然是全球范围内的主要死因之一。近十年来,我国 AMI 发病率快速上升,死亡率居高不下。对于 AMI 的规范化救治依然任重而道远,在 AMI 患者中应用心脏肌钙蛋白早期诊断、非梗死相关血管处理优化再灌注治疗策略、新型抗血小板聚集药物优化药物治疗、区域协同救治网络和胸痛中心建设优化救治流程等方面仍有很大的提升空间。对 AMI 完成早期诊断和优化治疗具有非常重要的意义。

关键词: 心肌梗死, 早期诊断, 肌钙蛋白

Abstract:  In recent years, benefited from the progress of clinical studies of early diagnosis and early revascularization in acute myocardial infarction (AMI), the guidelines for Europe and the United States and the Chinese academic continue to be updated to guide our clinical practice. However, AMI still remains one of the major causes of death in the worldwide. Over the past 10 years, the incidence of AMI increased rapidly in China, and the mortality kept at a high level. There is still plenty of room to improve in the early diagnosis of cardiac troponin, revascularization strategy optimization of non-infarct-related vascular, optimized new antiplatelet therapy, development of regional synergies network and chest pain center. There is still a long way from the standardized treatment of AMI. It is very important to complete early diagnosis and optimum treatment of AMI.

Key words: myocardial infarction, early diagnosis, troponin

中图分类号: